Johns Hopkins Lyme Disease Research Center’s recently released Winter 2021 Newsletter addresses the confusing new IDSA guidelines, calls attention to the similarities between common COVID-19 long hauler symptoms and persistent Lyme disease, as well as provides insights to significant advances made by their Lyme disease clinical research program, despite challenges brought by the COVID-19 pandemic.
The study, “A murine model of lyme disease demonstrates that Borrelia burgdorferi colonizes the dura mater and induces inflammation in the central nervous system,” was published in the journal PLOS Pathogens. Prior to this, studies using inbred laboratory mice to observe B. burgdorferi infection and host immune responses in the central nervous system (CNS) were lacking, creating a major barrier to understanding the neuropathologies associated with Lyme disease.
Bartonella & Neuropsych/Ticks & Lyme by Co./476,000 Lyme Diagnoses/Pike Co. Tick Results Video/LDA 2020 Success/NIH Ivermectin Rec/Judge Orders Ivermectin/Lyme Bacteria in New Tick
Results of the study, “Bartonella Associated Cutaneous Lesions (BACL) in People with Neuropsychiatric Symptoms” was recently published in the journal, Pathogens, as part of the special issue, “The Evolving Biomedical Importance of Bartonella Species Infections” / A new summary article by employees of the CDC presents the first county-level map of the distribution of Lyme disease spirochetes in host-seeking Ixodes pacificus and Ixodes scapularis ticks between 2004-2019 in the contiguous United States. / and more…
The Pike County (PA) Tick Borne Diseases Task Force has provided a 6 minute video slide show with results from the Pike County Tick Borne Diseases Base-Line Study, a county-wide assessment of the tick-borne diseases and infection rates of ticks funded in part by a 2018 grant awarded by the LDA. From Spring 2018 […]
On January 14, 2021, The National Institute of Health (NIH) COVID-19 Treatment Guidelines Panel issued a change in position and are no longer recommending “against” the use of ivermectin for the treatment of COVID-19. This “permission” was issued 8 days after Drs. Paul Marik and Pierre Kory, founding members of the Front Line Covid-19 Critical […]
The study “Borrelia burgdorferi Sensu Stricto DNA in Field-Collected Haemaphysalis longicornis Ticks, Pennsylvania, United States” was recently published in the Centers for Disease Control & Prevention (CDC) Emerging Infectious Diseases. Pennsylvania has the highest number of reported Lyme disease cases in the US.
Does Bartonella Contribute to the Occurrence of Cutaneous Lesions and Neuropsychiatric Symptoms in Patients?
Results of the study, “Bartonella Associated Cutaneous Lesions (BACL) in People with Neuropsychiatric Symptoms” was recently published in the journal, Pathogens, as part of the special issue, “The Evolving Biomedical Importance of Bartonella Species Infections.” The study’s authors describe Bartonella spp. test results for participants who reported neuropsychiatric symptoms, with a majority reporting the concurrent incidence of cutaneous lesions.
The CDC published, in the February edition of its “Emerging Infectious Diseases,” two new papers pertaining to Lyme disease case numbers. CDC indicates that the researchers found ~ 476,000 people are diagnosed with and treated for Lyme disease each year in the U.S. This is a 59% increase from their previous estimate of ~300,000. Also, CDC posted a new page to its website, Syndromic Surveillance of Emergency Department Visits for Tick Bites, showing tick bites by time, age/sex, and region.
The Lyme Disease Association, Inc. (LDA) has been working for Lyme and tick-borne diseases (TBD) for 30 years, with individuals who are patients and family members of patients driving the programs. We care about you, your family, your friends, your pets, who have or might acquire Lyme disease and other TBD. That is why ~97% of our funds generally go directly to programs. Over time, LDA has awarded 120 research grants resulting in 53 peer-reviewed journal articles− one published in 2020 by Columbia University’s Brian Fallon, MD. The LDA partnered to help to establish the endowed Columbia University Lyme & Tick-Borne Diseases Research Center 13 years ago. The “Brain, Behavior & Immunity” article conclusion states:
Pat Smith’s Letter on How LDA’s Work Has Helped Lyme Patients. Dear Lyme Community & Those Concerned about Lyme and TBD, This year has been a challenge for all of us, and in particular, for those with chronic conditions such as Lyme disease, which is still unrecognized by the federal government. The Lyme Disease Association, Inc. (LDA) has been working for Lyme and tick-borne diseases (TBD) for 30 years, with individuals who are patients and family members of patients driving the programs…